199 related articles for article (PubMed ID: 27708683)
1. Microarray analysis of gene expression in liver, adipose tissue and skeletal muscle in response to chronic dietary administration of NDGA to high-fructose fed dyslipidemic rats.
Zhang H; Shen WJ; Li Y; Bittner A; Bittner S; Tabassum J; Cortez YF; Kraemer FB; Azhar S
Nutr Metab (Lond); 2016; 13():63. PubMed ID: 27708683
[TBL] [Abstract][Full Text] [Related]
2. Effect of Creosote Bush-Derived NDGA on Expression of Genes Involved in Lipid Metabolism in Liver of High-Fructose Fed Rats: Relevance to NDGA Amelioration of Hypertriglyceridemia and Hepatic Steatosis.
Zhang H; Li Y; Hu J; Shen WJ; Singh M; Hou X; Bittner A; Bittner S; Cortez Y; Tabassum J; Kraemer FB; Azhar S
PLoS One; 2015; 10(9):e0138203. PubMed ID: 26394137
[TBL] [Abstract][Full Text] [Related]
3. Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARα-dependent and -independent pathways.
Zhang H; Shen WJ; Cortez Y; Kraemer FB; Azhar S
Am J Physiol Gastrointest Liver Physiol; 2013 Jan; 304(1):G72-86. PubMed ID: 23104557
[TBL] [Abstract][Full Text] [Related]
4. Nordihydroguaiaretic Acid, a Lignan from
Chan JKW; Bittner S; Bittner A; Atwal S; Shen WJ; Inayathullah M; Rajada J; Nicolls MR; Kraemer FB; Azhar S
J Pharmacol Exp Ther; 2018 May; 365(2):281-290. PubMed ID: 29472517
[TBL] [Abstract][Full Text] [Related]
5. Anti-hyperlipidaemic effects of synthetic analogues of nordihydroguaiaretic acid in dyslipidaemic rats.
Singh M; Bittner S; Li Y; Bittner A; Han L; Cortez Y; Inayathullah M; Arif Z; Parthasarathi R; Rajadas J; Shen WJ; Nicolls MR; Kraemer FB; Azhar S
Br J Pharmacol; 2019 Feb; 176(3):369-385. PubMed ID: 30374952
[TBL] [Abstract][Full Text] [Related]
6. Creosote bush-derived NDGA attenuates molecular and pathological changes in a novel mouse model of non-alcoholic steatohepatitis (NASH).
Han L; Bittner S; Dong D; Cortez Y; Dulay H; Arshad S; Shen WJ; Kraemer FB; Azhar S
Mol Cell Endocrinol; 2019 Dec; 498():110538. PubMed ID: 31415794
[TBL] [Abstract][Full Text] [Related]
7. Masoprocol decreases serum triglyceride concentrations in rats with fructose-induced hypertriglyceridemia.
Scribner KA; Gadbois TM; Gowri M; Azhar S; Reaven GM
Metabolism; 2000 Sep; 49(9):1106-10. PubMed ID: 11016888
[TBL] [Abstract][Full Text] [Related]
8. Dietary supplementation with myo-inositol reduces hepatic triglyceride accumulation and expression of both fructolytic and lipogenic genes in rats fed a high-fructose diet.
Shimada M; Hibino M; Takeshita A
Nutr Res; 2017 Nov; 47():21-27. PubMed ID: 29241575
[TBL] [Abstract][Full Text] [Related]
9. Nordihydroguaiaretic acid protects against high-fat diet-induced fatty liver by activating AMP-activated protein kinase in obese mice.
Lee MS; Kim D; Jo K; Hwang JK
Biochem Biophys Res Commun; 2010 Oct; 401(1):92-7. PubMed ID: 20836990
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin treatment induced peroxisome proliferator-activated receptor alpha expression and decreased plasma nonesterified fatty acids and liver triglyceride in fructose-fed rats.
Roglans N; Sanguino E; Peris C; Alegret M; Vázquez M; Adzet T; Díaz C; Hernández G; Laguna JC; Sánchez RM
J Pharmacol Exp Ther; 2002 Jul; 302(1):232-9. PubMed ID: 12065722
[TBL] [Abstract][Full Text] [Related]
11. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
[TBL] [Abstract][Full Text] [Related]
12. Fructose supplementation worsens the deleterious effects of short-term high-fat feeding on hepatic steatosis and lipid metabolism in adult rats.
Crescenzo R; Bianco F; Coppola P; Mazzoli A; Tussellino M; Carotenuto R; Liverini G; Iossa S
Exp Physiol; 2014 Sep; 99(9):1203-13. PubMed ID: 24972835
[TBL] [Abstract][Full Text] [Related]
13. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
14. Chronic fructose intake does not induce liver steatosis and inflammation in female Sprague-Dawley rats, but causes hypertriglyceridemia related to decreased VLDL receptor expression.
Sangüesa G; Montañés JC; Baena M; Sánchez RM; Roglans N; Alegret M; Laguna JC
Eur J Nutr; 2019 Apr; 58(3):1283-1297. PubMed ID: 29516226
[TBL] [Abstract][Full Text] [Related]
15. A Grape Seed Procyanidin Extract Ameliorates Fructose-Induced Hypertriglyceridemia in Rats via Enhanced Fecal Bile Acid and Cholesterol Excretion and Inhibition of Hepatic Lipogenesis.
Downing LE; Heidker RM; Caiozzi GC; Wong BS; Rodriguez K; Del Rey F; Ricketts ML
PLoS One; 2015; 10(10):e0140267. PubMed ID: 26458107
[TBL] [Abstract][Full Text] [Related]
16. Altered mRNA expression of hepatic lipogenic enzyme and PPARalpha in rats fed dietary levan from Zymomonas mobilis.
Kang SA; Hong K; Jang KH; Kim YY; Choue R; Lim Y
J Nutr Biochem; 2006 Jun; 17(6):419-26. PubMed ID: 16214330
[TBL] [Abstract][Full Text] [Related]
17. Fructose supplementation impairs rat liver autophagy through mTORC activation without inducing endoplasmic reticulum stress.
Baena M; Sangüesa G; Hutter N; Sánchez RM; Roglans N; Laguna JC; Alegret M
Biochim Biophys Acta; 2015 Feb; 1851(2):107-16. PubMed ID: 25463011
[TBL] [Abstract][Full Text] [Related]
18. Changes in hepatic lipogenic and oxidative enzymes and glucose homeostasis induced by an acetyl-L-carnitine and nicotinamide treatment in dyslipidaemic insulin-resistant rats.
Ferreira MR; Camberos Mdel C; Selenscig D; Martucci LC; Chicco A; Lombardo YB; Cresto JC
Clin Exp Pharmacol Physiol; 2013 Mar; 40(3):205-11. PubMed ID: 23278446
[TBL] [Abstract][Full Text] [Related]
19. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice.
Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P
Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945
[TBL] [Abstract][Full Text] [Related]
20. The messenger RNA profiles in liver, hypothalamus, white adipose tissue, and skeletal muscle of female Zucker diabetic fatty rats after topiramate treatment.
Liang Y; She P; Wang X; Demarest K
Metabolism; 2006 Oct; 55(10):1411-9. PubMed ID: 16979414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
